U.S. markets close in 2 hours 14 minutes

Clover Health Investments, Corp. (CLOV)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
8.90+0.40 (+4.76%)
As of 1:46PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close8.50
Open8.55
Bid8.96 x 1300
Ask8.97 x 900
Day's Range8.51 - 9.30
52 Week Range6.31 - 17.45
Volume9,559,143
Avg. Volume24,551,756
Market Cap3.618B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est12.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Shareholder Alert: Robbins LLP is Investigating Clover Health Investments, Corp. (CLOV) on Behalf of Shareholders
      Business Wire

      Shareholder Alert: Robbins LLP is Investigating Clover Health Investments, Corp. (CLOV) on Behalf of Shareholders

      Shareholder rights law firm Robbins LLP is investigating Clover Health Investments, Corp. (NASDAQ: CLOV) on behalf of shareholders to determine whether certain Clover officers and directors violated the Securities Exchange Act of 1934 and breached their fiduciary duties to the Company. Clover Health provides medical insurance services.

    • Bragar Eagel & Squire is Investigating Certain Officers and Directors of Merit Medical Systems, Clover Health, and Zoom on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
      GlobeNewswire

      Bragar Eagel & Squire is Investigating Certain Officers and Directors of Merit Medical Systems, Clover Health, and Zoom on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

      NEW YORK, April 22, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating certain officers and directors of Merit Medical Systems, Inc. (NASDAQ: MMSI), Clover Health Investments Corp. (NASDAQ: CLOV), and Zoom Video Communications, Inc. (NASDAQ: ZM) on behalf of long-term stockholders. More information about each potential case can be found at the link provided. Merit Medical Systems, Inc. (NASDAQ: MMSI) Bragar Eagel & Squire is investigating certain officers and directors of Merit Medical Systems, Inc. following news that the Shareholder Class Action against Merit Medical has survived the motions to dismiss in the pending securities class action and may face damages. According to the securities class action complaint, during the class period defendants made false and misleading statements and/or failed to disclose adverse information concerning Merit’s business and prospects. Specifically, defendants failed to disclose that: (a) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (b) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; and (c) in light of the foregoing, the Company’s reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis. As a result of defendants’ material misrepresentations and omissions, Merit stock traded at artificially inflated prices of more than $62 per share. On March 29, 2021, U.S. District Judge David O. Carter denied defendants’ motions to dismiss plaintiffs’ claims, finding that plaintiffs had plausibly alleged securities fraud claims. For more information on our investigation into Merit Medical go to: https://bespc.com/cases/mmsi Clover Health Investments Corp. (NASDAQ: CLOV) Bragar Eagel & Squire is investigating certain officers and directors of Clover Health Investments Corp. following a class action complaint that was filed against Clover on February 5, 2021. The complaint alleges that throughout the class period defendants made materially false and misleading statements regarding the Company’s business. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Clover was the recipient of a Civil Investigative Demand from the DOJ; (ii) much of Clover’s sales are driven by a major related party deal that Clover not only failed to disclose but took active steps to conceal; (iii) Clover’s subsidiary Seek Insurance failed to disclose its relationship with Clover and misled consumers as to its purported independence; (iv) Clover’s software was in fact rudimentary; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times. For more information on our investigation into Clover go to: https://bespc.com/cases/clover Zoom Video Communications, Inc. (NASDAQ: ZM) Bragar Eagel & Squire is investigating certain officers and directors of Zoom Video Communications, Inc. following a class action complaint that was filed against Zoom on April 7, 2020. The Complaint alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Zoom had inadequate data privacy and security measures; (ii) contrary to Zoom’s assertions, the Company’s video communications service was not end-to-end encrypted; (iii) as a result of all the foregoing, users of Zoom’s communications services were at an increased risk of having their personal information accessed by unauthorized parties, including Facebook; (iv) usage of the Company’s video communications services was foreseeably likely to decline when the foregoing facts came to light; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times. For more information on our investigation into Zoom go to: https://bespc.com/cases/ZM About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes. Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq. Melissa Fortunato, Esq.Marion Passmore, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

    • Update: Chamath-Backed Clover Health in Apparent Squeeze with Massive Short Interest Reminiscent of GameStop
      IPO-Edge.com

      Update: Chamath-Backed Clover Health in Apparent Squeeze with Massive Short Interest Reminiscent of GameStop

      Chamath Palihapitiya By Jarrett Banks and John Jannarone Short interest in Chamath Palihapitiya-backed Clover Health Investments Corp. (Nasdaq: CLOV) is at 40.6 million shares, data compiled by financial analytics firm S3 Partners shows. This reflects approximately 37% of the float according to an updated estimate from FactSet, which changed over the weekend after IPO Edge covered the […]